Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11.

Köppel A, de Vries H, Jamili M, Stanke C, Brandl U, Leipold E, Heinemann SH

Open source

DOI
10.1016/j.ebr.2026.100897
Published
2026 Dec
Container
Epilepsy & behavior reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebr.2026.100897,
  title = {Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11.},
  author = {Köppel A and de Vries H and Jamili M and Stanke C and Brandl U and Leipold E and Heinemann SH},
  year = {2026},
  journal = {Epilepsy \& behavior reports},
  doi = {10.1016/j.ebr.2026.100897},
  url = {https://doi.org/10.1016/j.ebr.2026.100897}
}

RIS

TY  - JOUR
TI  - Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11.
AU  - Köppel A
AU  - de Vries H
AU  - Jamili M
AU  - Stanke C
AU  - Brandl U
AU  - Leipold E
AU  - Heinemann SH
PY  - 2026
JO  - Epilepsy & behavior reports
DO  - 10.1016/j.ebr.2026.100897
UR  - https://doi.org/10.1016/j.ebr.2026.100897
ER  - 

APA

A, K., H, D. V., M, J., C, S., U, B., E, L., & SH, H. (2026). Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11.. Epilepsy & behavior reports. https://doi.org/10.1016/j.ebr.2026.100897

Source records